Page last updated: 2024-11-02

oxotremorine and Hyperesthesia

oxotremorine has been researched along with Hyperesthesia in 2 studies

Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.

Hyperesthesia: Increased sensitivity to cutaneous stimulation due to a diminished threshold or an increased response to stimuli.

Research Excerpts

ExcerptRelevanceReference
"Oxotremorine was administered intrathecally."1.35Muscarinic receptor activation potentiates the effect of spinal cord stimulation on pain-related behavior in rats with mononeuropathy. ( Linderoth, B; Meyerson, BA; Song, Z, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, Z1
Meyerson, BA1
Linderoth, B1
Ben-Sreti, MM1
Sewell, RD1

Other Studies

2 other studies available for oxotremorine and Hyperesthesia

ArticleYear
Muscarinic receptor activation potentiates the effect of spinal cord stimulation on pain-related behavior in rats with mononeuropathy.
    Neuroscience letters, 2008, May-02, Volume: 436, Issue:1

    Topics: Animals; Cold Temperature; Combined Modality Therapy; Electric Stimulation Therapy; Electrodes, Impl

2008
Centrally-mediated hyperalgesia in mice produced by the antimuscarinic agents atropine and hyoscine.
    The Journal of pharmacy and pharmacology, 1981, Volume: 33, Issue:6

    Topics: Animals; Atropine; Humans; Hyperalgesia; Hyperesthesia; Mice; Nociceptors; Oxotremorine; Receptors,

1981